TransMedics Group, Inc.

NasdaqGM:TMDX Stok Raporu

Piyasa değeri: US$2.7b

TransMedics Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

TransMedics Group şirketinin toplam hissedar öz sermayesi $209.9M ve toplam borcu $508.5M olup, bu da borç-öz sermaye oranını 242.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $785.6M ve $575.7M dir. TransMedics Group 'in FAVÖK'ü $33.5M faiz karşılama oranı -73.2 dur. Şirketin $330.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

242.2%

Borç/özkaynak oranı

US$508.53m

Borç

Faiz karşılama oranı-73.2x
NakitUS$330.09m
EşitlikUS$209.92m
Toplam yükümlülüklerUS$575.65m
Toplam varlıklarUS$785.57m

Son finansal sağlık güncellemeleri

Recent updates

TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)

Nov 12

What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash

Oct 30
What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash

TransMedics: Mistakes Have Been Made, Here's My Updated Outlook

Oct 29

TransMedics' Organ Care: Critical Innovation With Lofty Expectations

Oct 23

TransMedics Group: This Could Be One Of The Biggest Moats In A Decade

Oct 16

Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

Sep 18
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

TransMedics: Take Profits While The Valuation Is Sky High

Sep 18

TransMedics: Wide Moat Player At A Lower Valuation Than Peers

Sep 10

TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

Aug 28
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

TransMedics: Heart And Lungs Will Drive The Next Leg Higher

Aug 19

Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: TMDX 'nin kısa vadeli varlıkları ( $492.5M ) kısa vadeli yükümlülüklerini ( $60.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: TMDX 'un kısa vadeli varlıkları ( $492.5M ) uzun vadeli yükümlülüklerini ( $515.6M ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: TMDX 'nin net borç/öz sermaye oranı ( 85% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: TMDX şirketinin borç/öz sermaye oranı son 5 yılda 53.8% seviyesinden 242.2% seviyesine yükseldi.

Borç Kapsamı: TMDX 'nin borcu işletme nakit akışı ( 7.4% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: TMDX ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.


Bilanço


Sağlıklı şirketleri keşfedin